A.S.K.-PrEP

(Assistance Services Knowledge-PrEP)

What We Do: A.S.K.-PrEP is a research study evaluating advancement along the PrEP Care Continuum and reductions in substance use among trans women and men who have sex with men with a substance use disorder.  The A.S.K.-PrEP study is also conducting a cost-effectiveness analysis to estimate the cost of implementing and sustaining each intervention.

A.S.K.-PrEP is a 5-session PrEP navigation intervention with weekly text-messaging support, designed to advance participants toward PrEP initiation, adherence, and persistence.

Following the completion of all enrollment procedures, participants are randomized (by chance) into either the A.S.K.-PrEP (i.e., PrEP navigation) intervention or standard of care (i.e., no intervention). At the 3-month follow-up evaluation, participants in the A.S.K.-PrEP intervention are assessed to either continue with their current intervention or to be re-randomized to receive added attention to their drug use.

Participants are asked to complete all enrollment procedures in-person at the study site in Hollywood, and 4 follow-up assessments, also completed in-person at the Hollywood study site. Enrollment and follow-up procedures include a behavioral assessment completed on a laptop, a urine drug screen, a HIV antigen/antibody test and, for those that have initiated daily oral-PrEP, a blood fingerstick test to assess adherence. Participants may earn up to $435 or $1,030 (based on randomization and study participation) in gift cards.

Enrollment: Open. Call or text 323-493-6824.

Study participants are trans women and men who have sex with men who use drugs, are HIV negative, and are 18 years or older.

Potential participants must either screen online (click here) or call to screen for eligibility before they can participate in the study.

Hours: Weekdays, 9:00 AM - 5:00 PM, with evening and weekend appointments based on availability.

Contact: 323-493-6824 (call or text)

Funding Source: This project is funded by the National Institute on Drug Abuse.